During the European Hematology Association (EHA) 2024 Hybrid Congress, the Lymphoma Hub and Multiple Myeloma Hub held a joint satellite symposium entitled: Sequencing immune-based therapies in B-cell malignancies. Here, the Lymphoma Hub is pleased to share a real-world patient case, real-world evidence and experience, and treatment optimization of chimeric antigen receptor (CAR) T-cell therapy in patients with large B-cell lymphoma (LBCL), presented by Ulrich Jäger, Medical University of Vienna, Vienna, AT.
","author_name":"Scientific Education Support"}